FY2025 EPS Estimate for Henry Schein Lowered by Analyst

Key Points

• Henry Schein's earnings per share (EPS) estimate for FY2025 has been lowered to $4.81 by Leerink Partners, down from a previous estimate of $4.82, while the consensus estimate remains at $4.74.
• JPMorgan Chase & Co. has reduced its price target for Henry Schein from $80.00 to $76.00 while keeping an "overweight" rating on the stock.
• Shares of Henry Schein opened at $63.39, reflecting a market capitalization of $7.69 billion and a PE ratio of 20.45.

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Stock analysts at Leerink Partnrs cut their FY2025 earnings per share estimates for Henry Schein in a research report issued to clients and investors on Tuesday, October 14th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $4.81 per share for the year, down from their previous estimate of $4.82. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein's FY2026 earnings at $5.21 EPS.

A number of other research analysts also recently issued reports on the company. Weiss Ratings restated a "hold (c)" rating on shares of Henry Schein in a research note on Wednesday, October 8th. JPMorgan Chase & Co. cut their price target on Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Barrington Research reiterated an "outperform" rating and set a $78.00 price target on shares of Henry Schein in a research note on Tuesday, September 23rd. Robert W. Baird reiterated a "neutral" rating and set a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Finally, Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target for the company in a research note on Tuesday, August 26th. Five analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Up 0.6%

Shares of NASDAQ:HSIC opened at $63.39 on Wednesday. The company has a market capitalization of $7.69 billion, a PE ratio of 20.45, a price-to-earnings-growth ratio of 2.08 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The business has a fifty day moving average price of $67.31 and a two-hundred day moving average price of $68.72. Henry Schein has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter last year, the company posted $1.23 EPS. The company's quarterly revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS.

Institutional Trading of Henry Schein

A number of institutional investors have recently added to or reduced their stakes in HSIC. CYBER HORNET ETFs LLC purchased a new stake in shares of Henry Schein in the 2nd quarter valued at about $25,000. MUFG Securities EMEA plc purchased a new stake in shares of Henry Schein in the 2nd quarter valued at about $27,000. Rakuten Securities Inc. purchased a new stake in shares of Henry Schein in the 1st quarter valued at about $34,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Henry Schein in the 2nd quarter valued at about $43,000. Finally, Steph & Co. purchased a new stake in shares of Henry Schein in the 2nd quarter valued at about $44,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.